Research and Markets: PharmaHandbook 6th Edition: a Guide to the International Pharmaceutical Industry - Volume 2, Emerging Markets
* Reuters is not responsible for the content in this press release.
DUBLIN--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/ee4801/pharmahandbook_6th) has announced the addition of the "PharmaHandbook 6th Edition: A Guide to the International Pharmaceutical Industry - Volume 2, Emerging Markets" report to their offering. The prescription drug industry is among the most globalized and the most heavily regulated - in the world. PharmaHandbook is an essential resource for anyone required to navigate the complexities of the global pharmaceutical marketplace. Our customers have called PharmaHandbook "invaluable", "extremely useful", "a wonderful resource" and say they "look forward to receiving it every year." In previous editions PharmaHandbook has been a single volume publication containing analysis of 40 global markets; however, after careful consideration and discussions with a number of customers, VOI has decided to break PharmaHandbook 2009 (sixth edition) into two separate volumes. The volumes will breakdown along the lines of Developed Markets and Emerging Markets Other licensing options are available, please contact customer services for more information Key Topics Covered: Emerging Markets - Volume II (August, 2009) Asia Pacific * China * India * Indonesia * Taiwan * Thailand * Vietnam EU EU General * Czech Republic * Hungary * Poland * Romania Europe-Non EU * Russia Latin America * Argentina * Brazil * Chile * Mexico * Venezuela ME / Africa * Egypt * Turkey * South Africa For more information visit http://www.researchandmarkets.com/research/ee4801/pharmahandbook_6th Laura Wood Senior Manager press@researchandmarkets.com Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters